Literature DB >> 15834465

Solid lipid nanoparticles as drug delivery systems.

K Manjunath1, J S Reddy, V Venkateswarlu.   

Abstract

For a decade, trials have been made to utilize solid lipid nanoparticles (SLNs) as alternative drug delivery systems to colloidal drug delivery systems such as lipid emulsions, liposomes, and polymeric nanoparticles. Various lipid matrices, surfactants, and other excipients used in formulation, preparation methods, sterilization and lyophilization of SLNs are discussed in this article. Entrapment efficiency of drug carrier and its effect on physical parameters, drug release, and release mechanisms of various compositions are reviewed and discussed. Important points in characterization and stability of SLNs are outlined. Various in vitro studies carried out by different research groups are mentioned in addition to in vivo evaluation. Exploitation potential of SLNs to administer by various routes of administration are covered. Passive and active drug targeting using SLNs are presented. Copyright 2005 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834465     DOI: 10.1358/mf.2005.27.2.876286

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  35 in total

1.  Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design.

Authors:  Mayank Shah; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2010-03-23       Impact factor: 3.246

Review 2.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

3.  Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles.

Authors:  LianDong Hu; Qianbin Xing; Jian Meng; Chuang Shang
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

Review 4.  Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.

Authors:  Surajit Das; Anumita Chaudhury
Journal:  AAPS PharmSciTech       Date:  2010-12-21       Impact factor: 3.246

5.  Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.

Authors:  R Minelli; L Serpe; P Pettazzoni; V Minero; G Barrera; Cl Gigliotti; R Mesturini; A C Rosa; P Gasco; N Vivenza; E Muntoni; R Fantozzi; U Dianzani; G P Zara; C Dianzani
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.

Authors:  Ketan Hippalgaonkar; Goutham R Adelli; Kanchan Hippalgaonkar; Michael A Repka; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-19       Impact factor: 2.671

Review 7.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

8.  Modification of composition of a nanoemulsion with different cholesteryl ester molecular species: effects on stability, peroxidation, and cell uptake.

Authors:  Cristina P Almeida; Carolina G Vital; Thais C Contente; Durvanei A Maria; Raul C Maranhão
Journal:  Int J Nanomedicine       Date:  2010-09-20

Review 9.  Solid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent Breakthroughs.

Authors:  Jafar Ezzati Nazhad Dolatabadi; Hadi Valizadeh; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2015-06-15

10.  Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats.

Authors:  Reham I Amer; Ghada E Yassin; Reem A Mohamed; Ahmed M Fayez
Journal:  AAPS PharmSciTech       Date:  2021-07-13       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.